StrategIQ Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.91M | Buy |
4,993
+1
| +0% | +$584 | 0.33% | 72 |
|
|
2023
Q3 | $2.68M | Sell |
4,992
-83
| -2% | -$42.8K | 0.31% | 73 |
|
|
2023
Q2 | $2.38M | Buy |
5,075
+31
| +0.6% | +$13K | 0.27% | 80 |
|
|
2023
Q1 | $1.73M | Buy |
5,044
+25
| +0.5% | +$8.43K | 0.2% | 93 |
|
|
2022
Q4 | $1.84M | Buy |
5,019
+95
| +2% | +$33.7K | 0.21% | 87 |
|
|
2022
Q3 | $1.59M | Buy |
4,924
+2
| +0% | +$634 | 0.2% | 90 |
|
|
2022
Q2 | $1.6M | Buy |
4,922
+10
| +0.2% | +$3K | 0.19% | 92 |
|
|
2022
Q1 | $1.41M | Hold |
4,912
| – | – | 0.15% | 112 |
|
|
2021
Q4 | $1.36M | Buy |
4,912
+743
| +18% | +$188K | 0.14% | 110 |
|
|
2021
Q3 | $963K | Sell |
4,169
-100
| -2% | -$24.7K | 0.19% | 101 |
|
|
2021
Q2 | $980K | Hold |
4,269
| – | – | 0.19% | 96 |
|
|
2021
Q1 | $798K | Sell |
4,269
-100
| -2% | -$19.6K | 0.17% | 112 |
|
|
2020
Q4 | $738K | Buy |
4,369
+314
| +8% | +$46.9K | 0.17% | 113 |
|
|
2020
Q3 | $600K | Buy |
4,055
+75
| +2% | +$11.6K | 0.15% | 120 |
|
|
2020
Q2 | $653K | Hold |
3,980
| – | – | 0.18% | 105 |
|
|
2020
Q1 | $552K | Sell |
3,980
-285
| -7% | -$39.2K | 0.17% | 111 |
|
|
2019
Q4 | $561K | Buy |
4,265
+519
| +14% | +$60.2K | 0.14% | 131 |
|
|
2019
Q3 | $419K | Buy |
3,746
+270
| +8% | +$30.1K | 0.12% | 141 |
|
|
2019
Q2 | $385K | Hold |
3,476
| – | – | 0.11% | 146 |
|
|
2019
Q1 | $451K | Sell |
3,476
-200
| -5% | -$24.3K | 0.14% | 131 |
|
|
2018
Q4 | $425K | Hold |
3,676
| – | – | 0.15% | 129 |
|
|
2018
Q3 | $394K | Sell |
3,676
-23
| -0.6% | -$2.3K | 0.12% | 129 |
|
|
2018
Q2 | $316K | Sell |
3,699
-200
| -5% | -$16.4K | 0.11% | 139 |
|
|
2018
Q1 | $302K | Hold |
3,899
| – | – | 0.12% | 135 |
|
|
2017
Q4 | $329K | Hold |
3,899
| – | – | 0.13% | 118 |
|
|
2017
Q3 | $334K | Hold |
3,899
| – | – | 0.13% | 106 |
|
|
2017
Q2 | $321K | Buy |
3,899
+150
| +4% | +$12.2K | 0.14% | 110 |
|
|
2017
Q1 | $315K | Buy |
3,749
+200
| +6% | +$16K | 0.14% | 107 |
|
|
2016
Q4 | $261K | Buy |
3,549
+100
| +3% | +$7.45K | 0.13% | 108 |
|
|
2016
Q3 | $277K | Buy |
3,449
+18
| +0.5% | +$1.44K | 0.15% | 97 |
|
|
2016
Q2 | $270K | Buy |
3,431
+495
| +17% | +$37.3K | 0.16% | 89 |
|
|
2016
Q1 | $211K | Hold |
2,936
| – | – | 0.2% | 53 |
|
|
2015
Q4 | $247K | Buy |
+2,936
| New | +$244K | 0.25% | 50 |
|
Other funds holding LLY
StrategIQ Financial Group's LLY Position: Q4 2023 in Review
StrategIQ Financial Group increased its Eli Lilly (LLY) stake by 0.02% in Q4 2023, buying an estimated $584 and bringing the position to 4,993 shares worth $2.91M. The position accounts for 0.33% of the portfolio, ranked #72.
StrategIQ Financial Group first reported a position in LLY in Q4 2015 and has held it in 33 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.
- StrategIQ Financial Group held 4,993 shares of Eli Lilly worth $2.91M as of Q4 2023.
- StrategIQ Financial Group bought 1 Eli Lilly share in Q4 2023, an estimated $584.
- Eli Lilly made up 0.33% of StrategIQ Financial Group's portfolio in Q4 2023, its #72 holding.
- StrategIQ Financial Group first reported a position in Eli Lilly in Q4 2015 and has held it in 33 quarters since.
- 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.
Based on StrategIQ Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.